UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy

Oncotarget, 2015-10, Vol.6 (30), p.30287-30294

2015

Volltextzugriff (PDF)

Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes

Radiotherapy and oncology, 2010-05, Vol.95 (2), p.178-184

2010

Volltextzugriff (PDF)

Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non–Small-cell Lung Cancer: Results of a Phase II Study

Clinical lung cancer, 2018-03, Vol.19 (2), p.157-162

2018

Volltextzugriff (PDF)

Brief Report: Long-Term Follow-Up of Adjuvant Pembrolizumab After Locally Ablative Therapy for Oligometastatic NSCLC

JTO clinical and research reports, 2024-06, Vol.5 (6), p.100667, Article 100667

2024

Volltextzugriff (PDF)

Impact of PET Staging in Limited-Stage Small-Cell Lung Cancer

Journal of thoracic oncology, 2013-07, Vol.8 (7), p.899-905

2013

Volltextzugriff (PDF)

Adjuvant radiotherapy for completely resected stage 2 thymoma

Cancer, 2011-08, Vol.117 (15), p.3502-3508

2011

Volltextzugriff (PDF)

Determinants of Survival in Advanced Non–Small-Cell Lung Cancer in the Era of Targeted Therapies

Clinical lung cancer, 2013-09, Vol.14 (5), p.581-591

2013

Volltextzugriff (PDF)

Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-Small Cell Lung Cancer Receiving Sequential Treatment

American journal of clinical oncology, 2018-04, Vol.41 (4), p.391-395

2018

Volltextzugriff (PDF)

Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer

Cancer, 2012-11, Vol.118 (22), p.5580-5587

2012

Volltextzugriff (PDF)

Utility of Hypertension as a Surrogate Marker for Efficacy of Antiangiogenic Therapy in NSCLC

Anticancer research, 2012-11, Vol.32 (11), p.4629-4638

EVANS, Tracey

2012

Volltextzugriff (PDF)

The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Before Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung Cancer

Clinical lung cancer, 2018-03, Vol.19 (2), p.e205-e209

2018

Volltextzugriff (PDF)

THE PUBLIC INTEREST IN JUDICIAL MANAGEMENT

Singapore journal of legal studies, 2013-12 (December 2013), p.278-300

Chan, Tracey Evans

2013

Volltextzugriff (PDF)

Treatment of Stage IV Non-small Cell Lung Cancer

Chest, 2013-05, Vol.143 (5), p.e341S-e368S

2013

Volltextzugriff (PDF)

Emerging uses of circulating tumor DNA in advanced stage non-small cell lung cancer

Annals of translational medicine, 2017-09, Vol.5 (18), p.380-380

2017

Volltextzugriff (PDF)

Emerging treatment options for patients with recurrent advanced thymic epithelial tumors

OncoTargets and therapy, 2012-01, Vol.5, p.177-184

Evans, Tracey L

2012

Volltextzugriff (PDF)

Pretreatment Red Blood Cell Total Folate Concentration Is Associated With Response to Pemetrexed in Stage IV Nonsquamous Non–Small-cell Lung Cancer

Clinical lung cancer, 2017-03, Vol.18 (2), p.e143-e149

2017

Volltextzugriff (PDF)

The Impact of Extent and Location of Mediastinal Lymph Node Involvement on Survival in Stage III Non-Small Cell Lung Cancer Patients Treated With Definitive Radiotherapy

International journal of radiation oncology, biology, physics, 2012-05, Vol.83 (1), p.340-347

2012

Volltextzugriff (PDF)

Highlights from the Tenth World Conference on Lung Cancer

The oncologist (Dayton, Ohio), 2004-04, Vol.9 (2), p.232-238

Evans, Tracey L.

2004

Volltextzugriff (PDF)

Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating study

Practical Radiation Oncology, 2015-07, Vol.5 (4), p.e355-e363

2015

Volltextzugriff (PDF)

Pretreatment red blood cell total folate is associated with response to pemetrexed in stage IV non-squamous non-small-cell lung cancer

Clinical lung cancer, 2016-10, Vol.18 (2), p.e143-e149

2016

Volltextzugriff (PDF)

MET amplification (amp) as a resistance mechanism to osimertinib

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.9020-9020

2017

Volltextzugriff (PDF)

Role of chemotherapy in the management of advanced thymic tumors

Seminars in thoracic and cardiovascular surgery, 2005, Vol.17 (1), p.41-50

2005

Volltextzugriff (PDF)

The regulatory challenges of international transplant medicine: Developments in Singapore

Medical law international, 2012-12, Vol.12 (3-4), p.277-299

Chan, Tracey Evans

2012

Volltextzugriff (PDF)

Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non–Small Cell Lung Cancer: A Phase 2 Trial

JAMA oncology, 2019-09, Vol.5 (9), p.1283

2019

Volltextzugriff (PDF)

What helps the mother of a preterm infant become securely attached, responsive and well-adjusted?

Infant behavior & development, 2012-02, Vol.35 (1), p.1-11

2012

Volltextzugriff (PDF)

26 – 50 von 446

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(358)
Mit Volltextzugriff
(387)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(440)
Deutsch
(1)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy

Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes

Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non–Small-cell Lung Cancer: Results of a Phase II Study

Brief Report: Long-Term Follow-Up of Adjuvant Pembrolizumab After Locally Ablative Therapy for Oligometastatic NSCLC

Impact of PET Staging in Limited-Stage Small-Cell Lung Cancer

Adjuvant radiotherapy for completely resected stage 2 thymoma

Determinants of Survival in Advanced Non–Small-Cell Lung Cancer in the Era of Targeted Therapies

Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-Small Cell Lung Cancer Receiving Sequential Treatment

Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer

Utility of Hypertension as a Surrogate Marker for Efficacy of Antiangiogenic Therapy in NSCLC

The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Before Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung Cancer

THE PUBLIC INTEREST IN JUDICIAL MANAGEMENT

Treatment of Stage IV Non-small Cell Lung Cancer

Emerging uses of circulating tumor DNA in advanced stage non-small cell lung cancer

Emerging treatment options for patients with recurrent advanced thymic epithelial tumors

Pretreatment Red Blood Cell Total Folate Concentration Is Associated With Response to Pemetrexed in Stage IV Nonsquamous Non–Small-cell Lung Cancer

The Impact of Extent and Location of Mediastinal Lymph Node Involvement on Survival in Stage III Non-Small Cell Lung Cancer Patients Treated With Definitive Radiotherapy

Highlights from the Tenth World Conference on Lung Cancer

Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating study

Pretreatment red blood cell total folate is associated with response to pemetrexed in stage IV non-squamous non-small-cell lung cancer

MET amplification (amp) as a resistance mechanism to osimertinib

Role of chemotherapy in the management of advanced thymic tumors

The regulatory challenges of international transplant medicine: Developments in Singapore

Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non–Small Cell Lung Cancer: A Phase 2 Trial

What helps the mother of a preterm infant become securely attached, responsive and well-adjusted?

Suchergebnisse filtern